Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.34M Buy
15,175
+616
+4% +$220K 0.52% 58
2025
Q4
$4.77M Sell
14,559
-223
-2% -$70.7K 0.48% 56
2025
Q3
$4.17M Sell
14,782
-2
-0% -$580 0.42% 59
2025
Q2
$4.13M Buy
14,784
+875
+6% +$248K 0.44% 63
2025
Q1
$4.33M Buy
13,909
+430
+3% +$127K 0.48% 60
2024
Q4
$3.51M Buy
13,479
+280
+2% +$83.1K 0.37% 68
2024
Q3
$4.25M Buy
13,199
+203
+2% +$66.4K 0.44% 63
2024
Q2
$4.06M Sell
12,996
-2,364
-15% -$694K 0.45% 61
2024
Q1
$4.37M Buy
15,360
+223
+1% +$65.3K 0.44% 64
2023
Q4
$4.36M Sell
15,137
-81
-0.5% -$22.1K 0.38% 72
2023
Q3
$4.09M Buy
15,218
+147
+1% +$36.7K 0.38% 73
2023
Q2
$3.35M Sell
15,071
-2,440
-14% -$566K 0.31% 80
2023
Q1
$4.23M Buy
17,511
+1,150
+7% +$282K 0.35% 79
2022
Q4
$4.3M Sell
16,361
-150
-0.9% -$40.2K 0.36% 80
2022
Q3
$3.72M Sell
16,511
-167
-1% -$40.5K 0.33% 84
2022
Q2
$4.06M Sell
16,678
-110
-0.7% -$27K 0.33% 83
2022
Q1
$4.06M Buy
16,788
+150
+0.9% +$34.5K 0.27% 90
2021
Q4
$3.74M Sell
16,638
-1,075
-6% -$227K 0.23% 98
2021
Q3
$3.77M Buy
17,713
+155
+0.9% +$35.7K 0.25% 94
2021
Q2
$4.28M Buy
17,558
+1,663
+10% +$409K 0.29% 87
2021
Q1
$3.95M Buy
15,895
+300
+2% +$71.6K 0.3% 85
2020
Q4
$3.59M Buy
15,595
+8,669
+125% +$2M 0.29% 81
2020
Q3
$1.76M Hold
6,926
0.18% 96
2020
Q2
$1.63M Sell
6,926
-53
-0.8% -$12.1K 0.18% 95
2020
Q1
$1.41M Hold
6,979
0.19% 94
2019
Q4
$1.68M Hold
6,979
0.18% 101
2019
Q3
$1.54M Buy
6,979
+53
+0.8% +$10.2K 0.17% 106
2019
Q2
$1.28M Sell
6,926
-100
-1% -$17.9K 0.14% 112
2019
Q1
$1.33M Sell
7,026
-533
-7% -$102K 0.15% 108
2018
Q4
$1.47M Sell
7,559
-201
-3% -$39.2K 0.19% 101
2018
Q3
$1.61M Sell
7,760
-332
-4% -$65.4K 0.17% 108
2018
Q2
$1.49M Hold
8,092
0.17% 105
2018
Q1
$1.38M Sell
8,092
-498
-6% -$91.4K 0.15% 109
2017
Q4
$1.49M Buy
8,590
+71
+0.8% +$12.6K 0.16% 105
2017
Q3
$1.59M Sell
8,519
-820
-9% -$145K 0.18% 98
2017
Q2
$1.61M Sell
9,339
-6,300
-40% -$1.02M 0.18% 98
2017
Q1
$2.57M Sell
15,639
-775
-5% -$129K 0.3% 85
2016
Q4
$2.4M Hold
16,414
0.29% 84
2016
Q3
$2.74M Sell
16,414
-75
-0.5% -$12.7K 0.33% 84
2016
Q2
$2.51M Hold
16,489
0.31% 85
2016
Q1
$2.47M Buy
16,489
+1,605
+11% +$238K 0.31% 83
2015
Q4
$2.42M Sell
14,884
-166
-1% -$26.1K 0.31% 83
2015
Q3
$2.08M Hold
15,050
0.29% 84
2015
Q2
$2.31M Sell
15,050
-400
-3% -$64.1K 0.29% 87
2015
Q1
$2.47M Sell
15,450
-1,010
-6% -$159K 0.31% 81
2014
Q4
$2.62M Hold
16,460
0.32% 79
2014
Q3
$2.31M Hold
16,460
0.29% 83
2014
Q2
$1.95M Sell
16,460
-465
-3% -$53.8K 0.24% 87
2014
Q1
$2.09M Buy
16,925
+295
+2% +$35.8K 0.27% 82
2013
Q4
$1.9M Sell
16,630
-1,020
-6% -$116K 0.25% 83
2013
Q3
$1.98M Buy
17,650
+32
+0.2% +$3.47K 0.28% 81
2013
Q2
$1.74M Buy
+17,618
New +$1.83M 0.26% 86

Other funds holding AMGN

Tower Bridge Advisors's AMGN Position: Q1 2026 in Review

Tower Bridge Advisors increased its Amgen (AMGN) stake by 4.2% in Q1 2026, buying an estimated $220K and bringing the position to 15,175 shares worth $5.34M. The position accounts for 0.52% of the portfolio, ranked #58.

Tower Bridge Advisors first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Tower Bridge Advisors held 15,175 shares of Amgen worth $5.34M as of Q1 2026.
  • Tower Bridge Advisors bought 616 Amgen shares in Q1 2026, an estimated $220K.
  • Amgen made up 0.52% of Tower Bridge Advisors's portfolio in Q1 2026, its #58 holding.
  • Tower Bridge Advisors first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Tower Bridge Advisors's 13F filing for Q1 2026, filed 12 May 2026.